Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 24000667)

1.

[Development of a diagnostic test system for early non-invasive detection of prostate cancer based on PCA3 mRNA levels in urine sediment using quantitative reverse tanscription polymerase chain reaction (qRT-PCR)].

Pavlov KA, Shkoporov AN, Khokhlova EV, Korchagina AA, Sidorenkov AV, Grigor'ev MÉ, Pushkar' DIu, Chekhonin VP.

Vestn Ross Akad Med Nauk. 2013;(5):45-51. Russian.

PMID:
24000667
2.

The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population.

Shen M, Chen W, Yu K, Chen Z, Zhou W, Lin X, Weng Z, Li C, Wu X, Tao Z.

Exp Mol Pathol. 2011 Feb;90(1):97-100. doi: 10.1016/j.yexmp.2010.10.009. Epub 2010 Oct 20.

PMID:
20970419
3.

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.

Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.

BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.

PMID:
22564540
4.

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.

Salami SS, Schmidt F, Laxman B, Regan MM, Rickman DS, Scherr D, Bueti G, Siddiqui J, Tomlins SA, Wei JT, Chinnaiyan AM, Rubin MA, Sanda MG.

Urol Oncol. 2013 Jul;31(5):566-71. doi: 10.1016/j.urolonc.2011.04.001. Epub 2011 May 19.

5.

A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.

Rigau M, Ortega I, Mir MC, Ballesteros C, Garcia M, Llauradó M, Colás E, Pedrola N, Montes M, Sequeiros T, Ertekin T, Majem B, Planas J, Ruiz A, Abal M, Sánchez A, Morote J, Reventós J, Doll A.

Prostate. 2011 Dec;71(16):1736-45. doi: 10.1002/pros.21390. Epub 2011 Apr 25.

PMID:
21520154
6.

PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.

Rigau M, Morote J, Mir MC, Ballesteros C, Ortega I, Sanchez A, Colás E, Garcia M, Ruiz A, Abal M, Planas J, Reventós J, Doll A.

Prostate. 2010 Dec 1;70(16):1760-7. doi: 10.1002/pros.21211.

PMID:
20672322
7.

Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.

Ochiai A, Okihara K, Kamoi K, Oikawa T, Shimazui T, Murayama S, Tomita K, Umekawa T, Uemura H, Miki T.

BJU Int. 2013 May;111(6):928-33. doi: 10.1111/j.1464-410X.2012.11683.x. Epub 2013 Jan 18.

PMID:
23331404
8.

Molecular PCA3 diagnostics on prostatic fluid.

van Gils MP, Cornel EB, Hessels D, Peelen WP, Witjes JA, Mulders PF, Rittenhouse HG, Schalken JA.

Prostate. 2007 Jun 1;67(8):881-7.

PMID:
17440939
9.

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.

Auprich M, Augustin H, Budäus L, Kluth L, Mannweiler S, Shariat SF, Fisch M, Graefen M, Pummer K, Chun FK.

BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.

PMID:
21939492
10.

Quadriplex model enhances urine-based detection of prostate cancer.

Jamaspishvili T, Kral M, Khomeriki I, Vyhnankova V, Mgebrishvili G, Student V, Kolar Z, Bouchal J.

Prostate Cancer Prostatic Dis. 2011 Dec;14(4):354-60. doi: 10.1038/pcan.2011.32. Epub 2011 Jul 26.

PMID:
21788966
11.

Progensa™ PCA3 test for prostate cancer.

Durand X, Moutereau S, Xylinas E, de la Taille A.

Expert Rev Mol Diagn. 2011 Mar;11(2):137-44. doi: 10.1586/erm.10.122.

PMID:
21405964
12.

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA.

Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6.

PMID:
12814669
13.

The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients.

Ng CF, Yeung R, Chiu PK, Lam NY, Chow J, Chan B.

Hong Kong Med J. 2012 Dec;18(6):459-65.

14.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H.

Eur Urol. 2011 Nov;60(5):1045-54. doi: 10.1016/j.eururo.2011.08.003. Epub 2011 Aug 25. Review.

PMID:
21871709
15.

The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.

Mearini E, Antognelli C, Del Buono C, Cochetti G, Giannantoni A, Nardelli E, Talesa VN.

Biomarkers. 2009 Jun;14(4):235-43. doi: 10.1080/13547500902807306.

PMID:
19489685
16.

A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer.

Ouyang B, Bracken B, Burke B, Chung E, Liang J, Ho SM.

J Urol. 2009 Jun;181(6):2508-13; discussion 2513-4. doi: 10.1016/j.juro.2009.01.110. Epub 2009 Apr 16.

17.

PCA3: from basic molecular science to the clinical lab.

Day JR, Jost M, Reynolds MA, Groskopf J, Rittenhouse H.

Cancer Lett. 2011 Feb 1;301(1):1-6. doi: 10.1016/j.canlet.2010.10.019. Epub 2010 Nov 18. Review.

PMID:
21093148
18.

Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases.

Crawford ED, Rove KO, Trabulsi EJ, Qian J, Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ, Glover WL Jr, Bostwick DG.

J Urol. 2012 Nov;188(5):1726-31. doi: 10.1016/j.juro.2012.07.023. Epub 2012 Sep 19.

PMID:
22998901
19.

Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine.

Cao DL, Ye DW, Zhu Y, Zhang HL, Wang YX, Yao XD.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):166-72. doi: 10.1038/pcan.2011.2. Epub 2011 Feb 15.

PMID:
21321584
20.

Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis.

Neves AF, Dias-Oliveira JD, Araújo TG, Marangoni K, Goulart LR.

Clin Chem Lab Med. 2013 Apr;51(4):881-7. doi: 10.1515/cclm-2012-0392.

PMID:
23241599
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk